Gene Query: RDH10

Dataset Description Geneva Score
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 238.6
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 106.62
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 100.72
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 98.72
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 96.91
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 94.76
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 93.87
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 90.81
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 90.81
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 81.97
Proliferation-correlated expression 79.93
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 78.66
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 74.39
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 73.41
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 70.9
RNA-seq of human fibroblasts after irradiation 69.2
Region-specific Innate Antiviral Responses of the Human Epididymis 68.07
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 66.2
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 66.2
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 60.33
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 58.56
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 57.0
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 55.61
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 55.61
PGE2 mediated gene expression changes in human cervical stromal cells 55.54
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 54.29
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 53.69
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 53.69
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 50.65
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 47.83
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 47.78
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 46.51
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 46.33
MicroRNA targetome analysis during HCMV infection 45.69
Aneuploidy triggers an immune response 45.69
A transcriptome-wide divergence in protein translation scales with LIN28B expression 45.65
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 44.5
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 44.5
Genome-wide chromatin analysis of Ewing sarcoma 43.74
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 43.74
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 42.78
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 41.95
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 41.69
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 41.26
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 39.55
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 38.94
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 38.94
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 38.76
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 38.65
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 38.46
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 38.42
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 38.37
NR2F2 study 38.37
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 38.14
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 37.71
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 37.49
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 37.35
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 36.62
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 36.52
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 36.05
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 36.05
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 35.17
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 34.72
RNA-seq of young and quiescent MRC-5 human fibroblasts 34.26
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 33.39
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 33.39
Generation of trichogenic adipose-derived stem cells by expression of three factors 33.33
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 33.25
TGF-β promotes genomic instability after loss of RUNX3 33.05
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 32.97
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 32.94
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 32.86
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 32.8
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 32.75
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 32.7
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 32.23
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 32.11
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 31.79
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 30.89
MYCi975 regulates MYC target genes 30.55
Differential gene expression in Jagged1 treated human dental pulp cells. 30.46
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 30.39
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 30.26
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 30.26
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 30.19
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 30.06
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 30.02
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 29.96
Effect of mitochondria deficiency on senescence-associated gene expression 29.95
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 29.14
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 29.14
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 28.67
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 28.67
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 28.24
Identification of global regulators of T-helper cell lineage specification 28.19
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 28.19
Total RNA-seq in ALL-SIL upon TLX1 knockdown 28.05
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 27.99
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 27.99
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 27.99
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 27.99
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 27.27
BET bromodomain inhibition 27.26
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 27.26
mRNA differential expression analysis in a human ex vivo model of chronic wounds 27.2
ARID1A regulates condensin II distribution and chromosomal partition 27.19
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 27.19
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 27.18
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 26.11
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 25.51
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 25.38
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 25.33
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 25.18
FBXW7 modulates stress response by post-translational modification of HSF1 25.18
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 25.1
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 25.1
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 24.77
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 24.58
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 24.48
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 24.48
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 24.46
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 24.46
Random mono-allelic expression in MECP2-mutated cells 24.37
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 24.29
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 24.24
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 24.14
Tumor exosome integrins determine organotropic metastasis 24.14
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 24.02
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 24.0
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 23.83
STRIPAK directs PP2A activity to promote oncogenic transformation 23.81
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 23.49
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 23.45
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 23.42
Expression profiling of converted and control dermal BJ fibroblasts 23.25
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 23.25
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 23.14
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 22.99
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 22.99
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 22.84
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 22.7
MYCi361 regulates MYC target genes 22.69
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 22.55
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 22.5
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 22.46
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 22.37
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 22.31
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 22.28
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 21.83
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 21.81
Uridylation by TUT4 and TUT7 marks mRNA for degradation 21.49
Investigation about fibroblasts of different origins in culture 21.4
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 21.23
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 21.15
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 21.09
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 21.09
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 21.09
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 20.98
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 20.87
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 20.72
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 20.7
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 20.66
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 20.61
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 20.38
SRSF2 mutations impair hematopoiesis and alter exon recognition 20.33
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 20.25
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 20.25
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 20.2
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 20.01
High level DNA repair gene expression in human ES cells 19.75
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 19.68
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 19.56
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 19.55
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 19.47
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 19.47
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 19.29
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 18.95
RNA-sequencing of human liver tissue 18.73
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 18.72
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 18.48
HNF1 regulates critical functions of the human epididymis epithelium. 18.48
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 18.22
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 18.02
Neurofibroma 17.88
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 17.88
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 17.88
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 17.81
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 17.77
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 17.52
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 17.52
Maturation of human iNSCs 17.34
Identification of differentially expressed genes between senescence and senescence bypass cells 17.13
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 17.1
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 17.1
Total RNA-seq in ALL-SIL upon JQ1 inhibition 16.92
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 16.91
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 16.59
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 16.56
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 16.53
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 16.52
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 16.5
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 16.46
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 16.24
Expression charcaterization of an internal protocol developed to differentiate RPE cells 16.23
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 16.18
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 16.18
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 16.06
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 15.89
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 15.87
ARID1A and ARID1B loss in HCT116 and TOV21G cells 15.81
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 15.8
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 15.8
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 15.8
p53 activity results in DNA replication fork processivity 15.71
Expression level comparison under dividing and quiescent states in human primary fibroblasts 15.7
JAK dependent survival of ALK- ALCL 15.64
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 15.57
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 15.56
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 15.5
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 15.49
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 15.49
Expression data from miR340 overexpressing human A549 cells 15.37
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 15.35
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 15.15
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 15.1
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 15.1
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 15.03
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 14.99
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 14.88
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 14.88
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 14.66
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 14.46
RNAseq analysis of ESRP regulated splicing events in prostate cancer 14.17
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 14.05
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 13.98
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 13.91
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 13.81
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 13.8
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 13.8
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 13.7
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 13.47
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 13.34
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 13.31
DAOY-Notch1/Notch2 knockout: transcriptome comparison 13.27
Integrin signaling regulates YAP/TAZ to control skin homeostasis 13.24
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 13.21
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 13.19
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 13.11
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 13.06
Lineage specific differentiation is influenced by state of human pluripotency 12.99
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 12.99
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 12.95
HNRNPL and its RNA Targets in Prostate Cancer 12.95
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 12.94
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 12.94
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 12.9
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 12.88
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 12.88
Transcriptome sequencing of K-562 cells 12.83
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 12.72
Nonpregnant and term pregnant human myometrial tissues 12.72
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 12.71
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 12.71
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 12.69
Effect of drugs on transcriptomic profiles 12.67
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 12.65
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 12.62
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 12.61
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 12.6
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 12.55
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  12.51
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 12.51
Irf9 function in immunity in mouse 12.46
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 12.46
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 12.41
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 12.41
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 12.31
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 12.3
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 12.3
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 12.1
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 11.99
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 11.95
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 11.92
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 11.9
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 11.9
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 11.88
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 11.8
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 11.79
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 11.79
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 11.75
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 11.64
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 11.63
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 11.59
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 11.59
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 11.54
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 11.51
Transcriptomic profiling of human peripheral blood-derived mast cells 11.51
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 11.45
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 11.45
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.38
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 11.33
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 11.16
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 11.16
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 11.13
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 11.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 11.11
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 10.94
Changes in human endometrial gland transcriptome over the window of implantation 10.93
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 10.9
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 10.85
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 10.84
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 10.8
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 10.8
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 10.77
X-Ray induced DNA-Hydroxymethylation changes 10.73
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 10.65
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 10.59
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 10.54
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 10.52
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 10.42
CHD1 regulates cell fate determination by activation of differentiation-induced genes 10.26
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 10.21
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 10.13
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 10.09
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 9.92
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 9.92
Zika virus infection reprograms global transcription of host cells to allow sustained infection 9.87
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 9.86
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 9.78
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 9.62
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 9.62
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 9.55
RNA sequencing of human mammary epithelial cells 9.54
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.5
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 9.37
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 9.28
Expression profiles of the four human major ectodermal lineages 9.16
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 9.12
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 8.98
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 8.98
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 8.85
RNA-seq analysis of the human fetal kidney. 8.79
Effect of nuclear IL-33 on gene expression 8.74
Genome-wide transcriptional response to random aneuploidy in human cells 8.66
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 8.65
RNA-seq analysis of breast cancer 8.6
RNA-seq analysis and shRNA screen of breast cancer 8.6
RNAseq of T-ALL upon long non coding rna purturbation 8.51
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 8.46
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 8.37
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 8.33
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 8.22
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 8.15
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 8.09
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 8.06
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 8.01
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 7.72
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 7.72
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 7.72
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 7.71
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 7.61
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 7.59
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.38
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 7.27
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 7.16
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 7.02
Reprogrammed myeloid cell transcriptomes in NSCLC 7.0
6.94
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 6.89
Identification of Sin3B regulated genes during quiescence 6.88
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.84
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 6.82
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 6.82
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 6.74
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 6.65
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 6.57
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 6.52
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 6.39
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.32
FOXP2's impact on the primate transcriptome 6.32
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 6.26
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 6.18
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 6.16
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.12
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 6.04
Cell responses to dysregulated VZV-induced cell-cell fusion 6.0
RNA-seq analysis upon ARID1B overexpression 5.69
The effect of Abl kinases on non-small cell carcinoma global transcriptome 5.59
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 5.22
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 5.13
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 5.1
TOP2B disturbed the quality of human oocytes with advanced maternal age 5.08
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 5.01
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 4.97
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.89
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.69
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.69
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 4.68
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 4.61
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 4.6
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 4.37
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 4.37
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 4.33
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 4.33
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 4.31
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.21
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 4.08
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 4.06
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.04
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 4.02
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 3.94
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.92
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.92
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 3.91
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.87
RNAseq analysis of ruxolitinib treated breast cancers 3.85
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 3.84
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.7
Identification of the role of polydom in neurofibromas 3.66
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.54
mRNA sequencing of oropharyngeal cancer cell lines 3.44
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 3.39
Single cell transcriptome of peritoneal cells 3.33
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 3.28
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 3.15
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 3.08
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 3.01
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 3.01
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 2.91
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 2.83
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 2.83
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.83
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 2.82
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.77
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.68
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.65
Loss of endometrial plasticity in recurrent pregnancy loss 2.65
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 2.47
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.35
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.35
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 2.32
Targeted enhancer activation by a subunit of the integrator complex 2.06
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.98
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.97
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 1.91
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.86
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 1.73
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.68
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.61
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.61
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.59
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.59
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.5
Engineering Patient-Specific Tissue Implants 1.45
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.42
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 1.4
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.26
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.26
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 1.19
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.15
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.08
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.08
Finding missing proteins from epigenetically manipulated human cells 1.07
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.06
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.06
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 1.06
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 1.06
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.06
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.03
RNA-Seq in PWS iPSC-derived neurons 1.0
BMS-470539 on human synovial fibroblasts 0.95
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.92
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.88
6mer seed toxicity in tumour suppressive microRNAs 0.87
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.81
Fusion discovery in breast cancer cell line 0.66
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.65
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.65
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.58
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.57
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.55
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.53
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.53
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 0.5
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.5
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.5
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.41
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.41
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.34
Gene expression of thyroid cancer cell lines 0.33
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.3
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.22
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.2
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.15
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.1
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.08
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.05
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.05
Identification of long noncoding RNAs in T-ALL cell lines 0.01
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation